Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001437749-25-009676
Filing Date
2025-03-27
Accepted
2025-03-27 20:30:21
Documents
2
Period of Report
2024-12-06

Document Format Files

Seq Description Document Type Size
1 FORM 3 rdgdoc.html 3  
1 FORM 3 rdgdoc.xml 3 4046
2 quartel_poa.htm EX-24 9823
  Complete submission text file 0001437749-25-009676.txt   15503
Mailing Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747
Business Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747 (321) 939-3416
ZEVRA THERAPEUTICS, INC. (Issuer) CIK: 0001434647 (see all company filings)

EIN.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 300 WASHINGTON STREET ONE GATEWAY CENTER, SUITE 351 NEWTON MA 02458
Business Address
Quartel Adrian W (Reporting) CIK: 0001910132 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36913 | Film No.: 25781140